X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4832) 4832
Book Chapter (9) 9
Dissertation (6) 6
Magazine Article (4) 4
Book / eBook (1) 1
Conference Proceeding (1) 1
Newsletter (1) 1
Publication (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3497) 3497
microbiology (1869) 1869
infectious diseases (1783) 1783
anti-bacterial agents - pharmacology (1604) 1604
acinetobacter baumannii - drug effects (1544) 1544
acinetobacter infections - drug therapy (1541) 1541
microbial sensitivity tests (1423) 1423
male (1391) 1391
female (1363) 1363
acinetobacter baumannii (1350) 1350
anti-bacterial agents - therapeutic use (1338) 1338
acinetobacter infections - microbiology (1267) 1267
pharmacology & pharmacy (1157) 1157
acinetobacter-baumannii (1091) 1091
infections (1075) 1075
drug resistance, multiple, bacterial (1056) 1056
middle aged (1006) 1006
antibiotics (962) 962
bacteria (931) 931
adult (889) 889
drug resistance (874) 874
acinetobacter baumannii - isolation & purification (854) 854
aged (854) 854
pseudomonas-aeruginosa (838) 838
colistin (805) 805
epidemiology (684) 684
drug resistance in microorganisms (677) 677
cross infection - microbiology (673) 673
nosocomial infections (671) 671
gram-negative bacteria (633) 633
health aspects (600) 600
acinetobacter (590) 590
drug resistance, bacterial (586) 586
acinetobacter infections - epidemiology (576) 576
cross infection - drug therapy (572) 572
pneumonia (553) 553
risk factors (547) 547
hospitals (533) 533
mortality (528) 528
acinetobacter baumannii - genetics (521) 521
antimicrobial resistance (500) 500
retrospective studies (494) 494
biochemical phenomena, metabolism, and nutrition (487) 487
intensive care units (480) 480
ventilator-associated pneumonia (472) 472
carbapenems - pharmacology (461) 461
animals (460) 460
research (454) 454
pseudomonas aeruginosa - drug effects (449) 449
infectious disease (444) 444
treatment outcome (438) 438
risk-factors (435) 435
resistance (427) 427
escherichia-coli (426) 426
antimicrobial agents (425) 425
pathogens (416) 416
acinetobacter - drug effects (410) 410
cross infection - epidemiology (408) 408
klebsiella-pneumoniae (407) 407
anti-bacterial agents - administration & dosage (404) 404
bacterial infections and mycoses (397) 397
infection (393) 393
pseudomonas aeruginosa (392) 392
aged, 80 and over (390) 390
immunology (384) 384
bacteremia (375) 375
beta-lactamases - genetics (369) 369
gram-negative bacterial infections - drug therapy (360) 360
gram-negative bacteria - drug effects (359) 359
tigecycline (353) 353
analysis (335) 335
antibiotic resistance (332) 332
adolescent (321) 321
colistin - therapeutic use (316) 316
medicine (314) 314
intensive-care-unit (302) 302
colistin - pharmacology (297) 297
critically-ill patients (297) 297
polycyclic compounds (293) 293
genes (292) 292
gram-negative bacterial infections - microbiology (290) 290
outbreak (290) 290
imipenem (287) 287
antibacterial agents (286) 286
bacterial proteins - genetics (276) 276
minocycline - analogs & derivatives (276) 276
research article (275) 275
emergence (273) 273
cross infection (271) 271
drug therapy (271) 271
therapy (270) 270
acinetobacter - isolation & purification (268) 268
bacterial pneumonia (267) 267
multidrug resistance (265) 265
enterobacteriaceae (263) 263
identification (260) 260
staphylococcus-aureus (259) 259
strains (256) 256
bacterial infections (255) 255
pseudomonas infections - drug therapy (255) 255
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4674) 4674
Spanish (65) 65
Portuguese (42) 42
French (38) 38
Chinese (29) 29
Turkish (24) 24
Japanese (22) 22
German (18) 18
Italian (11) 11
Polish (11) 11
Russian (8) 8
Romanian (7) 7
Korean (5) 5
Persian (4) 4
Serbian (3) 3
Czech (2) 2
Norwegian (2) 2
Slovak (2) 2
Arabic (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Burns, ISSN 0305-4179, 2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | URINARY-TRACT-INFECTION | MORTALITY | SURGERY | RISK-FACTORS | DERMATOLOGY | REPLACEMENT | BACTERIOLOGY | CATHETERS | INTENSIVE-CARE-UNIT | SURVEILLANCE | ASSOCIATION | BLOOD-STREAM INFECTIONS | CRITICAL CARE MEDICINE | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents
Journal Article
The Journal of infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial stewardship oversight significantly... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
Journal of preventive medicine and hygiene, ISSN 1121-2233, 2017, Volume 58, Issue 4, pp. E294 - E301
National efforts to curtail healthcare-associated infections (HAI) proliferated recently, though data detailing progress over time are limited... 
Bloodstream infections | Urinary tract infections | Antimicrobial resistance | Multidrug-resistant organisms | Surgical site infections | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Gram-Negative Bacterial Infections - microbiology | Young Adult | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Odds Ratio | Staphylococcus aureus | Enterococcus | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Logistic Models | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Streptococcus pneumoniae | Acinetobacter baumannii | Cross Infection - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | New York City - epidemiology | Surgical Wound Infection - microbiology | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Surgical Wound Infection - drug therapy | Adult | Female | Pseudomonas aeruginosa | Retrospective Studies | Staphylococcal Infections - microbiology | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Surgical Wound Infection - epidemiology | Klebsiella Infections - drug therapy | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Streptococcal Infections - epidemiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Streptococcal Infections - drug therapy | Aged | Klebsiella pneumoniae
Journal Article
Journal Article
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 01/2020, Volume 20, Issue 1, pp. 92 - 11
BackgroundMulti-drug resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa are major causes of nosocomial infections globally... 
INFECTIOUS DISEASES | baumannii | BACTERIA | NIs | aeruginosa | RISK | MDR | Ethiopia | Pseudomonas aeruginosa - isolation & purification | Humans | Middle Aged | Child, Preschool | Infant | Male | Microbial Sensitivity Tests | Young Adult | Anti-Bacterial Agents - therapeutic use | Surgical Wound Infection - drug therapy | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | Urinary Tract Infections - microbiology | Child | Tertiary Care Centers | Cross-Sectional Studies | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Bacteremia - drug therapy | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Adolescent | Referral and Consultation | Surgical Wound Infection - microbiology | Drug resistance in microorganisms | Demographic aspects | Septicemia | Surgical wound infections | Statistics | Complications and side effects | Pseudomonas aeruginosa infections | Analysis | Causes of | Urinary tract infections | Cross infection | Nosocomial infections | Drug therapy | Acinetobacter infections | Health care | Nosocomial infection | Diffusion rate | Intensive care | Intravenous administration | Laboratories | Infections | Urinary tract | Drug resistance | Blood | Piperacillin | Surgery | Pseudomonas aeruginosa | Chi square analysis | Meropenem | Urogenital system | Urine | Global health | Pathogens | Statistical analysis | Bacterial infections | Catheterization | Multidrug resistance | Antimicrobial agents | Statistical tests | Patients | Catheters | Urinary tract diseases | Hospitals | Antibiotics | Ampicillin | Skin | Intubation | Antimicrobial resistance | Ciprofloxacin | A. baumannii | P. aeruginosa
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1744-7666, 2014, Volume 16, Issue 2, pp. 159 - 177
Journal Article